ScoreWhy is Jiangsu Jibeier Pharmaceutical Co. Ltd. ?
1
Poor Management Efficiency with a low ROCE of 24.96%
- The company has been able to generate a Return on Capital Employed (avg) of 24.96% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 11.71% and Operating profit at 13.31% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 9.21% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 11.71% and Operating profit at 13.31% over the last 5 years
4
Negative results in Jun 26
- ROCE(HY) Lowest at 8.69%
- PRE-TAX PROFIT(Q) At CNY 66.17 MM has Fallen at -43.56%
- NET PROFIT(Q) At CNY 57.24 MM has Fallen at -42.63%
5
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 3.23% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -25.34% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jiangsu Jibeier Pharmaceutical Co. Ltd. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Jiangsu Jibeier Pharmaceutical Co. Ltd.
-21.74%
0.37
31.86%
China Shanghai Composite
0.9%
0.22
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.71%
EBIT Growth (5y)
13.31%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.41
Tax Ratio
13.97%
Dividend Payout Ratio
39.64%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.16%
ROE (avg)
9.21%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
1.89
EV to EBIT
16.30
EV to EBITDA
15.37
EV to Capital Employed
2.29
EV to Sales
3.96
PEG Ratio
1.10
Dividend Yield
2.07%
ROCE (Latest)
14.05%
ROE (Latest)
10.18%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by 0.7% (YoY
NET SALES(Q)
Highest at CNY 263.14 MM
-12What is not working for the Company
ROCE(HY)
Lowest at 8.69%
PRE-TAX PROFIT(Q)
At CNY 66.17 MM has Fallen at -43.56%
NET PROFIT(Q)
At CNY 57.24 MM has Fallen at -42.63%
CASH AND EQV(HY)
Lowest at CNY 1,650.09 MM
Here's what is working for Jiangsu Jibeier Pharmaceutical Co. Ltd.
Net Sales
Highest at CNY 263.14 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Raw Material Cost
Fallen by 0.7% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jiangsu Jibeier Pharmaceutical Co. Ltd.
Pre-Tax Profit
At CNY 66.17 MM has Fallen at -43.56%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 57.24 MM has Fallen at -42.63%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Cash and Eqv
Lowest at CNY 1,650.09 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Footer loading
